HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35191936.
- Also identified by DOI 10.1001/jama.2022.0293 and PMC identifier 8864507.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study assesses HIV and hepatitis C testing and treatment availability in US specialty substance use disorder treatment facilities that offered medication for opioid use disorder in 2017-2020, stratified between federally certified Opioid Treatment Programs (OTPs) and non-OTPs.
Medical subject headings
- HIV Infections
- Hepatitis C
- Opioid-Related Disorders
- Substance Abuse Treatment Centers